Accelerate novel drug candidate generation and optimize molecular profiles with AI.
What is Exscientia?
Exscientia: Accelerate novel drug candidate generation and optimize molecular profiles with AI. Zekai scores it 7.7 out of 10 after independent testing. Best for pharmaceutical R&D teams seeking to accelerate pipeline development and generate optimized drug candidates.
Zekai Verdict
- What is it?
- Exscientia leverages advanced AI to fundamentally redesign drug discovery, accelerating the identification of novel therapies.
- Best for
- Medicinal chemists and computational chemists benefit most from Exscientia's ability to rapidly explore and optimize…
- Price
- Pricing on request
- Zekai Score
- 7.7/10
Schrödinger
Insilico Medicine
Blank Bio
Recursion
AbCelleraFor pharmaceutical and biotech professionals, Exscientia is a leading AI platform that fundamentally redesigns and accelerates drug discovery. It empowers R&D teams to generate high-quality drug candidates more efficiently by applying advanced AI to the most time-consuming phases. Its proven ability to simultaneously design and optimize multiple candidate molecules offers a significant advantage in bringing novel therapies to patients faster.
See Exscientia in action
Try it with these prompts
Copy any prompt and paste it directly into the tool.
Analyze cellular disruptions driving disease by training AI on vast biological datasets. Input cell images and disease parameters to identify potential new drug targets for conditions with high unmet need.
Utilize AI models trained on proprietary biological and chemical datasets to design highly optimized molecules. Provide target information and desired chemical properties to generate potential first-in-class…
Leverage AI-driven platform to reduce time and cost from hit identification to IND-enabling studies. Input preclinical data and trial objectives to streamline the drug development process.
Prompts for Pharma
Trusted by professionals
Exscientia integrations
Best Exscientia alternatives
Exscientia vs. Schrödinger: Exscientia differentiates itself with an end-to-end, AI-first approach focused on rapidly generating novel drug candidates. Its platform excels at de novo design, simultaneously optimizing molecules against multiple parameters to accelerate the entire discovery cycle. In contrast, Schrödinger is renowned for its deep, physics-based computational platform, which provides highly accurate simulations and property predictions for known or proposed structures. A team might choose Exscientia for speed and innovation in early-stage discovery to build a pipeline, while leveraging Schrödinger for detailed, in-depth analysis and refinement of specific high-potential candidates, making the tools potentially complementary.
Is Exscientia worth it?
Why Pharmaceutical & Biotech choose this tool
Key Use Cases
Frequently asked questions
Does Exscientia offer a free trial?
What is the best use of Exscientia for Pharmaceutical R&D?
What integrations does Exscientia offer?
How does Exscientia provide value for money?
Exscientia pricing and plans
Prices and features are updated regularly but can change at any time — always confirm on the official website. Some links on this page are affiliate links.
Top 10 AI tools in this category
Take it with you
- The challenges of traditional R&D
- How AI is reshaping the paradigm
- AI for Target Identification
- Generative Chemistry & Molecule Design
- Multi-Parameter Candidate Optimization
Get Exscientia deal alerts
Be the first to know when Exscientia drops a new discount, adds features, or changes pricing.
More on AI for Pharmaceutical & Biotech
Latest AI news
About Exscientia
Full Description
Exscientia leverages advanced AI to fundamentally redesign drug discovery, accelerating the identification of novel therapies. It empowers pharmaceutical R&D professionals to generate high-quality drug candidates with optimized profiles more efficiently. This translates to faster pipeline development and improved patient outcomes.
